TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
CBUS

Cibus Global LLC

Healthcare · Biotechnology

1.10$ -8.1% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns Cibus Global LLC (CBUS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.9% of the shares are freely tradable; institutional investors hold 33.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 33.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 26.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 76Mio.

Largest Shareholders

Institutions

Institutions CBUS
Name Stake (%) Shares Change (%) Date
FMR Inc 14.98 11,449,660 +0.2 06/30/2026
Vanguard Capital Management, LLC 3.01 2,299,966 +8.6 06/30/2026
United Capital Financial Advisers Inc 0.75 576,043 +0.0 06/30/2026
Geode Capital Management, LLC 0.69 528,233 +9.4 06/30/2026
BlackRock Inc 0.64 492,795 +18.7 06/30/2026

Funds

Funds CBUS
Name Stake (%) Shares Change (%) Date
Fidelity Growth Company Fund 4.45 3,398,823 +0.0 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.10 1,602,469 +0.0 09/30/2026
Fidelity Growth Company K6 1.28 978,877 +0.0 08/31/2026
Fidelity Series Growth Company 1.11 848,628 +0.0 08/31/2026
Fidelity Blue Chip Growth 0.94 716,262 +0.4 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?